[Beta blockers and peripheral blood circulation. Can the restrictions for indication still be maintained?].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001775:Blood Circulation / Q000187:drug effects*; D005121:Extremities / Q000098:blood supply*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D011928:Raynaud Disease / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists
Beta-Blocker und periphere Durchblutung. Lässt sich die Indikationseinschränkung noch halten?